Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -34.7% | +27.3% | 2 / 3 | +68.0% | -1.97 pp | -1.67 pp | +10.7% | 1.67 | 5.95 | 389 | +68,0% | 7,8 | −8,5% | 5.95 | 8.72 | −31,8% |
| Pts | 0 | 4 | 8 | 12 | 4 | 4 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 8.200 (close price on 2026-10-14)EPS (TTM): 1.379
Financial charts
1.Revenue & growth
VND bn389Q2/26
1.Revenue & growth
VND bn389Q2/26
2.Profit & growth
VND bn7,79Q2/26
3.Profit mix (Penman)
VND bn29,1Q2/26
4.Margins & cost structure
%6.4%Q2/26
5.Returns & cash cycle
% · days6.8%Q2/26
6.Earnings quality & cash
VND bn70,0Q2/26
7.Asset structure
VND bn686Q2/26
8.Funding & debt health
VND bn · times686Q2/26
9.Revenue backlog
VND bn40,0Q2/26
10.Valuation
times · %7,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %623Q2/26
Adjusted EPS growth, latest quarter
-8.5%
Average adjusted EPS growth, 3 quarters
2.6%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26